Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kenta Futamura
Observed names:
Futamura Kenta,
Futamura, Kenta,
kenta futamura
Institutions:
Japanese Red Cross Nagoya Daiichi Hospital,
Japanese Red Cross Nagoya Daini Hospital
Observed institutions:
Aichi Medical University,
Japanese Red Cross Nagoya Daiichi Hospital,
Japanese Red Cross Nagoya Daini Hospital,
Nagoya University
OpenAlex ID:
A5108317663
The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial
2018
·
Makoto Tsujita
, Tomoki Kosugi
, et al.
·
Nephrology Dialysis Transplantation
·
48
PDF
Treatment for secondary hyperparathyroidism focusing on parathyroidectomy
2023
·
Takahisa Hiramitsu
, Yuki Hasegawa
, et al.
·
Frontiers in Endocrinology
·
46
PDF
Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study
2019
·
Takahisa Hiramitsu
, Toshihide Tomosugi
, et al.
·
Scientific Reports
·
34
PDF
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial
2020
·
Makoto Tsujita
, Yohei Doi
, et al.
·
Journal of Bone and Mineral Research
·
31
PDF
Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
2017
·
Norihiko Goto
, Ai Takahashi-Nakazato
, et al.
·
Transplantation Direct
·
29
Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 Diabetes
2023
·
Tetsuhiko Sato
, Yoshinori Azuma
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
27
PDF
Favorable results in ABO ‐incompatible renal transplantation without B cell‐targeted therapy: Advantages and disadvantages of rituximab pretreatment
2017
·
Manabu Okada
, Yoshihiko Watarai
, et al.
·
Clinical Transplantation
·
27
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
2024
·
Shigeyoshi Yamanaga
, Keita Shimata
, et al.
·
American Journal of Transplantation
·
23
PDF
Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak
2015
·
Norihiko Goto
, Kenta Futamura
, et al.
·
Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine
·
22
PDF
Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors
2019
·
Takahisa Hiramitsu
, Toshihide Tomosugi
, et al.
·
Kidney International Reports
·
20
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
2022
·
Manabu Okada
, Yoshihiro Tominaga
, et al.
·
BMC Nephrology
·
19
PDF
Clinical Significance of Shared T Cell Epitope Analysis in Early De Novo Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope Analysis
2021
·
Toshihide Tomosugi
, Kenta Iwasaki
, et al.
·
Frontiers in Immunology
·
19
Impact of Arterial Reconstruction With Recipient's Own Internal Iliac Artery for Multiple Graft Arteries on Living Donor Kidney Transplantation
2015
·
Takahisa Hiramitsu
, Kenta Futamura
, et al.
·
Medicine
·
19
Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
2021
·
Takahisa Hiramitsu
, Toshihide Tomosugi
, et al.
·
Kidney International Reports
·
16
5year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessment
2016
·
Takahisa Hiramitsu
, Manabu Okada
, et al.
·
International Immunopharmacology
·
15
Persistent hyperparathyroidism after preemptive kidney transplantation
2023
·
Manabu Okada
, Tetsuhiko Sato
, et al.
·
Clinical and Experimental Nephrology
·
12
PDF
Mid-Term Outcomes After Treatment for Antibody-Mediated Rejection by De Novo Donor-Specific HLA Antibody in Renal Transplant Recipients: Does Early Treatment Lead to Better Outcomes?
2020
·
Manabu Okada
, Toshihide Tomosugi
, et al.
·
Transplantation Proceedings
·
12
Death and kidney allograft dysfunction after bacteremia
2015
·
Kenta Ito
, Norihiko Goto
, et al.
·
Clinical and Experimental Nephrology
·
12
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study
2021
·
Yohei Doi
, Makoto Tsujita
, et al.
·
American Journal of Transplantation
·
11
PDF
Everolimus-based Immunosuppression Possibly Suppresses Mean Fluorescence Intensity Values of De Novo Donor-specific Antibodies After Primary Kidney Transplantation
2019
·
Shunji Narumi
, Yoshihiko Watarai
, et al.
·
Transplantation Proceedings
·
10
Optimal dose of rituximab in ABO‐incompatible kidney transplantation in patients with low anti‐A/B antibody titers: A single‐center retrospective cohort study
2023
·
Manabu Okada
, Shunji Narumi
, et al.
·
Clinical Transplantation
·
9
PDF
Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism
2021
·
Takahisa Hiramitsu
, Toshihide Tomosugi
, et al.
·
Journal of International Medical Research
·
9
PDF
Impact of grafting using thin upper pole artery ligation on living-donor adult kidney transplantation
2016
·
Takahisa Hiramitsu
, Manabu Okada
, et al.
·
Medicine
·
9
The importance of kidney volume as a marker in the assessment of living-donor kidney transplantation in Japan
2021
·
Makoto Tsujita
, Norihiko Goto
, et al.
·
Clinical and Experimental Nephrology
·
8
Impact of Age 70 years or Older on Donors for Living-Donor Kidney Transplantation
2024
·
Takahisa Hiramitsu
, Tomoki Himeno
, et al.
·
Kidney International Reports
·
7
PDF
Show more works
View as search
Works count:
105
Citation count:
610
H-index:
15
I10-index:
20
Year
Topic
Type